Potential use of fosfomycin-tromethamine for treatment of recurrent Campylobacter species enteritis

Juan Aguilar-Company, Ibai Los-Arcos, Carles Pigrau, Dolors Rodríguez-Pardo, María Nieves Larrosa, Virginia Rodríguez-Garrido, Denisse Sihuay-Diburga, Benito Almirante

    Research output: Contribution to journalArticleResearchpeer-review

    10 Citations (Scopus)

    Abstract

    Copyright © 2016, American Society for Microbiology. All Rights Reserved. We report 2 cases of recurrent Campylobacter coli enteritis caused by macrolide- and fluoroquinolone-resistant strains in 2 patients with hypogammaglobulinemia, successfully treated with a prolonged course of fosfomycin-tromethamine with no side effects. Fosfomycin-tromethamine may be a feasible alternative therapy for recurrent enteritis caused by Campylobacter species resistant to first-line drugs.
    Original languageEnglish
    Pages (from-to)4398-4400
    JournalAntimicrobial Agents and Chemotherapy
    Volume60
    Issue number7
    DOIs
    Publication statusPublished - 1 Jul 2016

    Fingerprint Dive into the research topics of 'Potential use of fosfomycin-tromethamine for treatment of recurrent Campylobacter species enteritis'. Together they form a unique fingerprint.

  • Cite this

    Aguilar-Company, J., Los-Arcos, I., Pigrau, C., Rodríguez-Pardo, D., Larrosa, M. N., Rodríguez-Garrido, V., Sihuay-Diburga, D., & Almirante, B. (2016). Potential use of fosfomycin-tromethamine for treatment of recurrent Campylobacter species enteritis. Antimicrobial Agents and Chemotherapy, 60(7), 4398-4400. https://doi.org/10.1128/AAC.00447-16